Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.23
0.070.76%
At close: -
$9.01
-0.22-2.38%
After Hours: 7:52 PM EDT
Comments
Loading...
89bio Analyst Ratings and Price Targets | NASDAQ:ETNB | Benzinga
89bio Inc has a consensus price target of $28.55 based on the ratings of 13 analysts. The high is $49 issued by Raymond James on November 8, 2024. The low is $11 issued by Goldman Sachs on March 14, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, Citigroup, and HC Wainwright & Co. on March 14, 2025, March 13, 2025, and February 28, 2025, respectively. With an average price target of $19 between Goldman Sachs, Citigroup, and HC Wainwright & Co., there's an implied 110.88% upside for 89bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Citigroup
HC Wainwright & Co.
UBS
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for 89bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | Buy Now | 22.09% | Goldman Sachs | Andrea Newkirk | → $11 | Initiates | → Neutral | Get Alert |
| 03/13/2025 | Buy Now | 177.47% | Citigroup | Geoff Meacham61% | → $25 | Initiates | → Buy | Get Alert |
| 02/28/2025 | Buy Now | 133.07% | HC Wainwright & Co. | Ed Arce58% | $29 → $21 | Reiterates | Buy → Buy | Get Alert |
| 02/04/2025 | Buy Now | — | Wolfe Research | Andy Chen38% | — | Initiates | → Outperform | Get Alert |
| 01/31/2025 | Buy Now | 321.75% | UBS | Eliana Merle43% | $25 → $38 | Maintains | Buy | Get Alert |
| 01/21/2025 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 01/02/2025 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 11/11/2024 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2024 | Buy Now | 443.84% | Raymond James | Steven Seedhouse58% | $53 → $49 | Maintains | Strong Buy | Get Alert |
| 09/20/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 08/06/2024 | Buy Now | 488.24% | Raymond James | Steven Seedhouse58% | $50 → $53 | Maintains | Strong Buy | Get Alert |
| 08/06/2024 | Buy Now | 33.19% | RBC Capital | Brian Abrahams48% | $13 → $12 | Maintains | Sector Perform | Get Alert |
| 08/06/2024 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 07/01/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/11/2024 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2024 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 266.26% | Evercore ISI Group | Liisa Bayko70% | $37 → $33 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | 221.86% | HC Wainwright & Co. | Ed Arce58% | $31 → $29 | Maintains | Buy | Get Alert |
| 04/22/2024 | Buy Now | 232.96% | B of A Securities | Alexandria Hammond41% | → $30 | Assumes | → Buy | Get Alert |
| 04/05/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | Buy Now | 244.06% | HC Wainwright & Co. | Ed Arce58% | $31 → $31 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | 244.06% | HC Wainwright & Co. | Ed Arce58% | $31 → $31 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | 310.65% | Evercore ISI Group | Liisa Bayko70% | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/06/2024 | Buy Now | 310.65% | Evercore ISI Group | Liisa Bayko70% | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/05/2024 | Buy Now | — | Oppenheimer | Jay Olson60% | — | Maintains | Perform | Get Alert |
| 03/04/2024 | Buy Now | 221.86% | Cantor Fitzgerald | Kristen Kluska70% | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 03/01/2024 | Buy Now | 55.38% | RBC Capital | Brian Abrahams48% | $15 → $14 | Maintains | Sector Perform | Get Alert |
| 03/01/2024 | Buy Now | 244.06% | HC Wainwright & Co. | Ed Arce58% | $32 → $31 | Maintains | Buy | Get Alert |
| 01/12/2024 | Buy Now | 66.48% | RBC Capital | Brian Abrahams48% | → $15 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/20/2023 | Buy Now | 255.16% | HC Wainwright & Co. | Ed Arce58% | $35 → $32 | Maintains | Buy | Get Alert |
| 12/05/2023 | Buy Now | 288.46% | HC Wainwright & Co. | Ed Arce58% | $35 → $35 | Reiterates | Buy → Buy | Get Alert |
| 11/28/2023 | Buy Now | 288.46% | HC Wainwright & Co. | Ed Arce58% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | 166.37% | RBC Capital | Brian Abrahams48% | $27 → $24 | Maintains | Outperform | Get Alert |
| 10/12/2023 | Buy Now | 177.47% | UBS | Eliana Merle43% | $36 → $25 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | 199.67% | RBC Capital | Brian Abrahams48% | $34 → $27 | Maintains | Outperform | Get Alert |
| 09/22/2023 | Buy Now | 277.36% | RBC Capital | Brian Abrahams48% | → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 08/28/2023 | Buy Now | 299.56% | UBS | Eliana Merle43% | → $36 | Initiates | → Buy | Get Alert |
| 08/10/2023 | Buy Now | 288.46% | HC Wainwright & Co. | Ed Arce58% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | Buy Now | 332.85% | Cantor Fitzgerald | Kristen Kluska70% | $41 → $39 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 277.36% | RBC Capital | Brian Abrahams48% | $33 → $34 | Maintains | Outperform | Get Alert |
| 07/03/2023 | Buy Now | 310.65% | BTIG | Justin Zelin40% | $30 → $37 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 443.84% | Evercore ISI Group | Liisa Bayko70% | → $49 | Initiates | → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 232.96% | Oppenheimer | Jay Olson60% | → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 05/08/2023 | Buy Now | 288.46% | HC Wainwright & Co. | Ed Arce58% | $30 → $35 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | 355.05% | Cantor Fitzgerald | Kristen Kluska70% | $40 → $41 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 266.26% | RBC Capital | Brian Abrahams48% | $36 → $33 | Maintains | Outperform | Get Alert |
| 03/23/2023 | Buy Now | 454.94% | Raymond James | Steven Seedhouse58% | $25 → $50 | Maintains | Strong Buy | Get Alert |
| 03/23/2023 | Buy Now | 232.96% | HC Wainwright & Co. | Ed Arce58% | $25 → $30 | Maintains | Buy | Get Alert |
| 03/22/2023 | Buy Now | 299.56% | RBC Capital | Brian Abrahams48% | $27 → $36 | Maintains | Outperform | Get Alert |
| 03/22/2023 | Buy Now | 454.94% | Raymond James | Steven Seedhouse58% | $25 → $50 | Maintains | Strong Buy | Get Alert |
| 03/22/2023 | Buy Now | 399.45% | Cantor Fitzgerald | Kristen Kluska70% | $34 → $45 | Maintains | Overweight | Get Alert |
| 03/20/2023 | Buy Now | 177.47% | HC Wainwright & Co. | Ed Arce58% | $27 → $25 | Maintains | Buy | Get Alert |
| 03/14/2023 | Buy Now | 199.67% | RBC Capital | Brian Abrahams48% | → $27 | Reiterates | → Outperform | Get Alert |
| 03/06/2023 | Buy Now | 277.36% | Cantor Fitzgerald | Kristen Kluska70% | → $34 | Reiterates | → Overweight | Get Alert |
| 02/21/2023 | Buy Now | 99.78% | Oppenheimer | Jay Olson60% | $12 → $18 | Maintains | Outperform | Get Alert |
| 02/07/2023 | Buy Now | 199.67% | HC Wainwright & Co. | Ed Arce58% | → $27 | Reiterates | → Buy | Get Alert |
| 11/11/2022 | Buy Now | 221.86% | RBC Capital | Brian Abrahams48% | $35 → $29 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | 177.47% | Raymond James | Steven Seedhouse58% | $14 → $25 | Maintains | Strong Buy | Get Alert |
| 08/17/2022 | Buy Now | 199.67% | HC Wainwright & Co. | Ed Arce58% | $26 → $27 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | 188.57% | HC Wainwright & Co. | Ed Arce58% | $29 → $26 | Maintains | Buy | Get Alert |
| 07/11/2022 | Buy Now | 221.86% | SVB Leerink | Thomas Smith33% | $50 → $29 | Maintains | Outperform | Get Alert |
| 06/30/2022 | Buy Now | 66.48% | Oppenheimer | Jay Olson60% | $40 → $15 | Maintains | Outperform | Get Alert |
| 06/30/2022 | Buy Now | 55.38% | Raymond James | Steven Seedhouse58% | $12 → $14 | Maintains | Strong Buy | Get Alert |
| 06/29/2022 | Buy Now | 166.37% | BTIG | Justin Zelin40% | $28 → $24 | Maintains | Buy | Get Alert |
FAQ
What is the target price for 89bio (ETNB) stock?
The latest price target for 89bio (NASDAQ:ETNB) was reported by Goldman Sachs on March 14, 2025. The analyst firm set a price target for $11.00 expecting ETNB to rise to within 12 months (a possible 22.09% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for 89bio (ETNB)?
The latest analyst rating for 89bio (NASDAQ:ETNB) was provided by Goldman Sachs, and 89bio initiated their neutral rating.
When was the last upgrade for 89bio (ETNB)?
There is no last upgrade for 89bio
When was the last downgrade for 89bio (ETNB)?
The last downgrade for 89bio Inc happened on January 12, 2024 when RBC Capital changed their price target from N/A to $15 for 89bio Inc.
When is the next analyst rating going to be posted or updated for 89bio (ETNB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 89bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 89bio was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.
Is the Analyst Rating 89bio (ETNB) correct?
While ratings are subjective and will change, the latest 89bio (ETNB) rating was a initiated with a price target of $0.00 to $11.00. The current price 89bio (ETNB) is trading at is $9.01, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
